Becker's Oncology Leadership Podcast

In this episode, Jodi Skiles, MD, Medical Director of the Pediatric Stem Cell Transplant Program at Riley Hospital for Children in Indianapolis, joins the podcast to discuss a groundbreaking milestone in pediatric medicine—the world's first bone marrow stem cell transplant using cells from a deceased donor in a 14-year-old patient. She shares the significance of expanding access to this innovative donor source and how advances in transplant medicine are creating new opportunities to improve outcomes for children in need of life-saving care.

In this episode, Dr. James McGee, Osf Healthcare Cancer Institute, discusses the urgent need to expand cancer prevention and early detection in rural communities while addressing the unique challenges rural providers face. He also shares his perspective on AI in oncology, the growing impact of obesity on cancer care, and emerging innovations that could improve access and reduce the cost of treatment.

In this episode, Jordan Johnson, MSHA, Bridge Oncology, ABA Health Law Oncology Advocacy, discusses the major CMS policy shifts reshaping oncology, the growing role of AI governance, and why healthcare leaders must think beyond reimbursement rates to prepare for the future of care delivery. He also shares advice for entrepreneurs on building systems thinking across finance, clinical care, compliance, and technology.

In this episode, Frantz M. Berthaud, MPH, FACHE, Senior Vice President, Oncology Services, University Medical Center of El Paso (UMC), discusses why cancer care leaders should measure both return on investment and return on humanity. He also shares insights on expanding oncology capacity, advancing health equity, and building a workforce and culture centered on compassionate, patient-focused care.

In this episode, Jeffrey E. Lee, M.D., Executive Vice President, Chief Physician Executive, The University of Texas MD Anderson, discusses how advances in cancer treatment are transforming survivorship care by improving outcomes while reducing treatment burden. He shares MD Anderson's approach to supporting patients beyond remission through personalized care, survivorship programs, and innovations that prioritize both longevity and quality of life.

In this episode, Theodoros Teknos, MD, President & Scientific Director of University Hospitals Seidman Cancer Center and the Jane and Lee Seidman Chair in Cancer Innovation, discusses the importance of recruiting top oncology talent, balancing research with clinical care, and using AI to improve patient outcomes. He also shares why continued investment in cancer research and scientific discovery is critical to accelerating the next generation of cancer breakthroughs.

In this episode, Dr. Robert Winn, Cancer Center Director at Fox Chase Cancer Center, Temple Health, shares his vision for expanding access to cutting edge cancer research by strengthening community partnerships and building trust in science. He also discusses the future of clinical trials, AI driven drug discovery, and accelerating innovation to improve cancer outcomes.

In this episode, Dr. Robert Figlin, Cedars-Sinai Cancer Institute, discusses improving patient access to specialized cancer care, expanding clinical trial opportunities, and using AI to streamline care delivery. He also shares why advances in research and innovation are giving oncology leaders more reason for optimism than ever before.

In this episode, Richard Barakat, MD, Physician-in-chief & Executive Director at Northwell Health Cancer Institute, discusses expanding access to advanced cancer therapies, integrating AI into oncology care, and driving the future of precision medicine. He also shares insights on improving efficiency, survivorship care, and clinical trial access for all patients.